# NSN 6505-01-066-6568: Loperamide Hydrochloride Capsule

NSN 6505-01-066-6568 (also written 6505010666568; NIIN 01-066-6568) is a loperamide hydrochloride capsule in Federal Supply Class 6505, Drugs and Biologicals. 2 manufacturer part numbers from 2 suppliers are on record. It was last purchased in Oct 2026.

## Identification

- NSN: 6505-01-066-6568 (6505010666568)
- NIIN: 01-066-6568 (010666568)
- Item name: LOPERAMIDE HYDROCHLORIDE CAPSULE
- Federal Supply Class: [FSC 6505 Drugs and Biologicals](https://nsnexplorer.com/fsc/6505/)
- Federal Supply Group: [FSG 65](https://nsnexplorer.com/group/65/)
- Acquisition method suffix code: AMSC 0 (observed 2026-10-10)
- Acquisition method code: 0

## Characteristics

| Code | Requirement | Reply |
| --- | --- | --- |
| AKJA | ACTIVE MEDICAMENT MEDICINAL STRENGTH | MILLIGRAMS LOPERAMIDE HYDROCHLORIDE ACTIVE INGREDIENT 2.000 |
| CQCT | PRIMARY CONTAINER TYPE | BOTTLE |
| CXCY | PART NAME ASSIGNED BY CONTROLLING AGENCY | LOPERAMIDE HYDROCHLORIDE CAPSULES USP 2MG 100S BT |
| CYLZ | CAPSULE PRIMARY CONTAINER CONTENT QUANTITY | 100.000 |
| MDES | MEDICAL DESIGNATION AND GRADE | UNITED STATES PHARMACOPEIA |

## Part numbers

| Part number | CAGE | Supplier | Source |
| --- | --- | --- | --- |
| NDC00093-0311-01 | 3V8D7 | TEVA PHARMACEUTICALS USA, INC. | [flis](https://www.dla.mil/Portals/104/Documents/InformationOperations/LogisticsInformationServices/FOIA/PUBLOG/) |
| NDC00378-2100-01 | 60895 | MYLAN PHARMACEUTICALS INC | [flis](https://www.dla.mil/Portals/104/Documents/InformationOperations/LogisticsInformationServices/FOIA/PUBLOG/) |

## Contract awards

Newest first.

| Date | Award | Description | Recipient | Amount |
| --- | --- | --- | --- | --- |
| 2026-10-08 | [SPE2DX25D8022/SPE2D927F0060](https://www.dibbs.bsm.dla.mil/Awards/AwdRecs.aspx?category=awdnsn&TypeSrch=cq&Value=6505010666568) | LOPERAMIDE HYDROCHLORIDE CAPSULES | CARDINAL HEALTH, INC. | $5.98 |
| 2026-10-06 | [SPE2DX25D8022/SPE2D927F0028](https://www.dibbs.bsm.dla.mil/Awards/AwdRecs.aspx?category=awdnsn&TypeSrch=cq&Value=6505010666568) | LOPERAMIDE HYDROCHLORIDE CAPSULES | CARDINAL HEALTH, INC. | $5.98 |
| 2026-10-01 | [SPE2DX25D9900/SPE2DP27F0004](https://www.dibbs.bsm.dla.mil/Awards/AwdRecs.aspx?category=awdnsn&TypeSrch=cq&Value=6505010666568) | LOPERAMIDE HYDROCHLORIDE CAPSULES | DMS PHARMACEUTICAL GROUP INC | $190.96 |
| 2026-10-01 | [SPE2DX25D9900/SPE2DP27F0033](https://www.dibbs.bsm.dla.mil/Awards/AwdRecs.aspx?category=awdnsn&TypeSrch=cq&Value=6505010666568) | LOPERAMIDE HYDROCHLORIDE CAPSULES | DMS PHARMACEUTICAL GROUP INC | $95.48 |
| 2026-10-01 | [SPE2DX25D9900/SPE2DP27F0034](https://www.dibbs.bsm.dla.mil/Awards/AwdRecs.aspx?category=awdnsn&TypeSrch=cq&Value=6505010666568) | LOPERAMIDE HYDROCHLORIDE CAPSULES | DMS PHARMACEUTICAL GROUP INC | $381.92 |
| 2026-10-01 | [SPE2DX25D9900/SPE2DP27F0038](https://www.dibbs.bsm.dla.mil/Awards/AwdRecs.aspx?category=awdnsn&TypeSrch=cq&Value=6505010666568) | LOPERAMIDE HYDROCHLORIDE CAPSULES | DMS PHARMACEUTICAL GROUP INC | $95.48 |
| 2026-10-01 | [SPE2DX25D9900/SPE2DP27F0041](https://www.dibbs.bsm.dla.mil/Awards/AwdRecs.aspx?category=awdnsn&TypeSrch=cq&Value=6505010666568) | LOPERAMIDE HYDROCHLORIDE CAPSULES | DMS PHARMACEUTICAL GROUP INC | $95.48 |
| 2026-10-01 | [SPE2DX25D9900/SPE2DP27F0067](https://www.dibbs.bsm.dla.mil/Awards/AwdRecs.aspx?category=awdnsn&TypeSrch=cq&Value=6505010666568) | LOPERAMIDE HYDROCHLORIDE CAPSULES | DMS PHARMACEUTICAL GROUP INC | $190.96 |
| 2026-09-29 | [SPE2DX25D9900/SPE2DP26F026P](https://www.dibbs.bsm.dla.mil/Awards/AwdRecs.aspx?category=awdnsn&TypeSrch=cq&Value=6505010666568) | LOPERAMIDE HYDROCHLORIDE CAPSULES | DMS PHARMACEUTICAL GROUP INC | $190.96 |
| 2026-09-29 | [SPE2DX25D9900/SPE2DP26F027M](https://www.dibbs.bsm.dla.mil/Awards/AwdRecs.aspx?category=awdnsn&TypeSrch=cq&Value=6505010666568) | LOPERAMIDE HYDROCHLORIDE CAPSULES | DMS PHARMACEUTICAL GROUP INC | $286.44 |
| 2026-09-28 | [SPE2DX25D9900/SPE2DP26F023D](https://www.dibbs.bsm.dla.mil/Awards/AwdRecs.aspx?category=awdnsn&TypeSrch=cq&Value=6505010666568) | LOPERAMIDE HYDROCHLORIDE CAPSULES | DMS PHARMACEUTICAL GROUP INC | $95.48 |
| 2026-09-25 | [SPE2DX25D8022/SPE2D926F9366](https://www.dibbs.bsm.dla.mil/Awards/AwdRecs.aspx?category=awdnsn&TypeSrch=cq&Value=6505010666568) | LOPERAMIDE HYDROCHLORIDE CAPSULES | CARDINAL HEALTH, INC. | $11.96 |
| 2026-09-25 | [SPE2DX25D9900/SPE2DP26F016K](https://www.dibbs.bsm.dla.mil/Awards/AwdRecs.aspx?category=awdnsn&TypeSrch=cq&Value=6505010666568) | LOPERAMIDE HYDROCHLORIDE CAPSULES | DMS PHARMACEUTICAL GROUP INC | $190.96 |
| 2026-09-24 | [SPE2DX25D8022/SPE2D926F9355](https://www.dibbs.bsm.dla.mil/Awards/AwdRecs.aspx?category=awdnsn&TypeSrch=cq&Value=6505010666568) | LOPERAMIDE HYDROCHL | CARDINAL HEALTH, INC. | $5.98 |
| 2026-09-22 | [SPE2DX25D9900/SPE2DP26F006L](https://www.dibbs.bsm.dla.mil/Awards/AwdRecs.aspx?category=awdnsn&TypeSrch=cq&Value=6505010666568) | LOPERAMIDE HYDROCHLORIDE CAPSULES | DMS PHARMACEUTICAL GROUP INC | $477.40 |

## Sources

- DLA DIBBS RFQs for this NSN: https://www.dibbs.bsm.dla.mil/RFQ/RFQNsn.aspx?value=6505010666568&category=nsn
- DLA DIBBS awards for this NSN: https://www.dibbs.bsm.dla.mil/Awards/AwdRecs.aspx?category=awdnsn&TypeSrch=cq&Value=6505010666568
- AMSC record: https://www.dla.mil/Portals/104/Documents/InformationOperations/LogisticsInformationServices/FOIA/PUBLOG/
- USAspending contract actions (each award above links to its record)
- All data is public U.S. government data; every row above links to its source record where one exists.

Canonical page: https://nsnexplorer.com/nsn/6505-01-066-6568/
JSON: https://nsnexplorer.com/api/nsn/6505-01-066-6568.json